Concepedia

Giancarlo Guido

GG

2

Publications

183

Citations

2

H-Index

2020

Active since

Affiliations

XBiotech (United States)(Current)

Giancarlo Guido is an author at XBiotech (United States) specializing in medicine, clinical trials, and metabolic syndrome.

Top concepts

MedicineHealthDiabetesPathologyDermatologySclerodermaPharmacologyClinical TrialsPharmacotherapyMetabolic Syndrome

Publications per year

2020–2023

2

Publications

2

Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial

Lori M. Laffel, Thomas Danne, Georgeanna J. Klingensmith et al. · The Lancet Diabetes & Endocrinology · 2023 · 98 citations · Full text

Metabolic Syndrome, Diabetes Management, Young People +11

A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain

Alice B. Gottlieb, Nicola E. Natsis, Francisco A. Kerdel et al. · Journal of Investigative Dermatology · 2020 · 85 citations

Inflammatory Lesions, Pathology, Clinical Dermatology +3

Rows per page

1–2 of 2